After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe in the short-term (12 weeks) for reducing phlegm in COPD.

The NE-U22V MicroAir®, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...

The Model 646 Nebulizer converts liquid into aerosol via ... it delivers consistent aerosol particles to the lungs of COPD patients.

Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...

For the 16 million Americans with chronic obstructive pulmonary disease (COPD), travel can be as anxiety-provoking as it is ...

It is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years. Ohtuvayre is delivered through a standard jet nebulizer and ...

Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...

Part B medication coverage is limited to drugs administered through durable medical equipment, including nebulizers and compressors ... in elderly patients with COPD.